{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_eculizumab",
            "via": [
              "target_CD5"
            ],
            "to": "DiseaseAtypicalHUS",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_ravulizumab",
            "via": [
              "target_CD5"
            ],
            "to": "DiseaseAtypicalHUS",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_aflibercept",
            "via": [
              "pathway_inflammatory_response"
            ],
            "to": "DiseaseAtypicalHUS",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "DiseaseAtypicalHUS",
          "type": "Disease",
          "label": "Atypical HUS",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_CD5",
          "type": "Target",
          "label": "CD5",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_renal_failure",
          "type": "Phenotype",
          "label": "Renal Failure",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_thrombocytopenia",
          "type": "Phenotype",
          "label": "Thrombocytopenia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_plasmapheresis",
          "type": "Treatment",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk_pathway",
          "type": "Pathway",
          "label": "RiskPathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adverse_phenotype",
          "type": "Phenotype",
          "label": "AdversePhenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Aflibercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Copanlisib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Belimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sunitinib",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "target_CD5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知的机制作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "target_CD5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知的机制作用"
        },
        {
          "source": "drug_aflibercept",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路间接调节"
        },
        {
          "source": "drug_corticosteroids",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路中常用药物"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "phenotype_renal_failure",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床通过形式改善症状"
        },
        {
          "source": "drug_methotrexate",
          "target": "phenotype_thrombocytopenia",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "具有影响血小板的潜力"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "phenotype_thrombocytopenia",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "具有影响血小板的潜力"
        },
        {
          "source": "drug_tacrolimus",
          "target": "phenotype_renal_failure",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "在肾脏相关代谢方面的应用"
        },
        {
          "source": "target_CD5",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "关键靶点关联"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "DiseaseAtypicalHUS",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与此型疾病的发病机制相关"
        },
        {
          "source": "drug_eculizumab",
          "target": "DiseaseAtypicalHUS",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接针对已知病理机制"
        },
        {
          "source": "drug_ravulizumab",
          "target": "DiseaseAtypicalHUS",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接针对已知病理机制"
        },
        {
          "source": "n_eculizumab",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能有旁路作用影响疗效"
        },
        {
          "source": "n_ravulizumab",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能有旁路作用影响疗效"
        },
        {
          "source": "n_aflibercept",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "作用机制可能与病理虚假相关"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能引发感染等风险"
        },
        {
          "source": "n_plasmapheresis",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "需要明确作用机理"
        },
        {
          "source": "n_methotrexate",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "长期使用可能导致肝损伤"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能引发感染和不良反应"
        },
        {
          "source": "n_tacrolimus",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "肾毒性风险需关注"
        },
        {
          "source": "n_copanlisib",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能有免疫抑制效应"
        },
        {
          "source": "n_rituximab",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "对某些感染风险的关联需明确"
        },
        {
          "source": "n_belimumab",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能影响免疫系统功能"
        },
        {
          "source": "n_sunitinib",
          "target": "n_risk_pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "潜在并发症风险需进一步评估"
        },
        {
          "source": "n_risk_pathway",
          "target": "n_adverse_phenotype",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "引发不良表型风险高"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_eculizumab",
              "target": "target_CD5",
              "relation": "acts_on",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "已知的机制作用"
            },
            {
              "source": "target_CD5",
              "target": "pathway_inflammatory_response",
              "relation": "involved_in",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "关键靶点关联"
            },
            {
              "source": "pathway_inflammatory_response",
              "target": "DiseaseAtypicalHUS",
              "relation": "causes",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "与此型疾病的发病机制相关"
            },
            {
              "source": "drug_eculizumab",
              "target": "DiseaseAtypicalHUS",
              "relation": "supports",
              "weight": 0.9,
              "agent": "Proponent",
              "rationale": "直接针对已知病理机制"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补齐 Eculizumab → CD5 → 炎症通路 → Atypical HUS，形成2条不相交路径"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_ravulizumab",
              "target": "target_CD5",
              "relation": "acts_on",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "已知的机制作用"
            },
            {
              "source": "target_CD5",
              "target": "pathway_inflammatory_response",
              "relation": "involved_in",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "关键靶点关联"
            },
            {
              "source": "pathway_inflammatory_response",
              "target": "DiseaseAtypicalHUS",
              "relation": "causes",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "与此型疾病的发病机制相关"
            },
            {
              "source": "drug_ravulizumab",
              "target": "DiseaseAtypicalHUS",
              "relation": "supports",
              "weight": 0.9,
              "agent": "Proponent",
              "rationale": "直接针对已知病理机制"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补齐 Ravulizumab → CD5 → 炎症通路 → Atypical HUS，形成2条不相交路径"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_aflibercept",
              "target": "pathway_inflammatory_response",
              "relation": "modulates",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "通路间接调节"
            },
            {
              "source": "pathway_inflammatory_response",
              "target": "DiseaseAtypicalHUS",
              "relation": "causes",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "与此型疾病的发病机制相关"
            },
            {
              "source": "drug_aflibercept",
              "target": "DiseaseAtypicalHUS",
              "relation": "supports",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "通过调节通路影响病理机制"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补齐 Aflibercept → 炎症通路 → Atypical HUS，形成2条不相交路径"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": []
  }
}